Laguna Hills, California, July 17, 2025 (Globe Newswire) – Hyperion Defi, Inc. (Nasdaq: Hyperion) (“Hyperion Defi” or “Company”), announced today that it would organize a special business update event on Tuesday July 29, 2025 at 2:00 p.m. and with the transformation of Cio Hyunsu and the CEO Rowe, to discuss the transformation of the company The company of AI Le Digital and the CEO Rowe Company in the first American company of the public list focused on the construction of a strategic treasure around media threw, the native token of the high performance hyperliquid blockchain.
To register,
Click here.
The event will provide a first glimpse of how Hyperion DEFI uses native blockchain assets such as beating media to build evolutionary and performance generators and support the growth of the hyperliquid ecosystem, mixing the advantages of a regulated public company with opportunities only available thanks to decentralized finances.
Star subjects will include:
-
The reasoning behind the transition from biopharmaceutical research to decentralized finance.
-
Why Hyperion Defi thinks that hyperliquid is the future of decentralized finance.
-
How Hyperion Defi has accumulated more than 1.4 million media tokens and launched a co-marked validator with Kinetiq to generate a yield and help secure the hyperliquid network.
-
The investment thesis behind the use of a cryptographic cash model to stimulate the value of long -term shareholders, providing retail investors and institutional investors, an exhibition kept at various chain strategies.
-
How the strategy creates value aggravated by impairment of development, the commitment of ecosystems and the development of proprietary financial products while continuing to work for the completion of the development and sale of the OPTEJETIA apparatus.
A live question and answers session will follow the official presentations.
On the hyperliquid platform and the mid-threshing token
The hyperliquid is a layer 1 (L1) blockchain optimized from the ground for transparent trading at high frequency. The blockchain includes fully perpetual perpetual works of Onchain, each order, cancellation, trade and liquidation occurring in the 70 milliseconds of blocks. It also hosts hyperevm, a platform of intelligent contract for general use which, like Ethereum, supports decentralized financial applications without authorization.
Médiatique is the native token of hyperliquid. The marked media threshing in particular provides useful users via reduced negotiation costs and increased reference bonuses. The media threshing in circulation is purchased and kidnapped independently by the blockchain itself with the negotiation costs generated on the command books of the network. In June 2025, more than 25 million media threw were sequestrated by this mechanism, and the token became the 12th largest cryptocurrency by market capitalization.
About Hyperion Defi, Inc.
Hyperion DEFI, Inc. is the first company listed on the public stock market to build a long -term strategic treasure of the native token of hyperliquid, media threshing. The company focuses on the supply of its shareholders, a simplified access to the hyperliquid ecosystem, one of the fastest and highest revenue blockchains in the world. The shareholders benefit from an exposure gradually aggravating media, both from its native return and additional income generated by its unique chain utility.
Hyperion DEFI also develops its owner -filled user (UFD) system which is designed to operate with a variety of topical ophthalmic liquids, including artificial tears and RECWET of lens. The project is particularly useful in chronic diseases on the front of the eye due to its improved ease of use, safety and tolerability and higher compliance potential compared to standard eye drops. Together, these advantages can cause compliance with higher treatment and better results for patients and providers.
For more information, please visit Hyperionefi.com.
Front instructions
With the exception of historical information, all the declarations, expectations and hypotheses contained in this press release are prospective declarations. Prospective declarations include, without limiting our approved products. These declarations are based on current expectations, estimates and projections concerning our company, in part, on the hypotheses made by management. These declarations are not guarantees of future performance and imply risks, uncertainties and hypotheses that are difficult to predict. Consequently, the real results and the results can, and in some cases, are likely to differ significantly from what is expressed or provided in prospective declarations due to many factors discussed from time to time in documents that we deposit with the Securities and Exchange American Commission.
In addition, such declarations could be affected by the risks and uncertainties linked, among others: the risks of our clinical trials, including, but without limiting themselves, the potential advantages of our products and the technology of the platform; the rate and degree of acceptance of the market and the clinical utility of our products; Our estimates concerning the potential market opportunity of our products; depended on third parties to develop and market our products; the ability of us and our partners to develop, implement and maintain manufacturing, marketing and marketing and strategies for our products; risks of intellectual property; Changes in legal, regulatory, legislative and geopolitical environments on the markets in which we operate and the impact of these changes on our ability to obtain the regulatory approval of our products and candidate products; our competitive position; Our ability to collect additional funds to maintain our commercial operations and make payments on our debt obligations as necessary; And the risks of our cryptocurrency strategy as detailed in our current report on the 8-K form filed on June 27, 2025.
All prospective declarations only speak on the date on which they are made, and unless it may be required under the laws applicable on securities, Hyperion DEFI does not have any obligation to update prospective declarations.
Hyperion Defi, Inc. Contact for investors:
Eric Ribner
Lifesci Advisors, LLC
(Protected by e-mail)
(646) 751-4363
